| __timestamp | Genmab A/S | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 850385000 | 9757000 |
| Thursday, January 1, 2015 | 1133041000 | 1253000 |
| Friday, January 1, 2016 | 1816122000 | 5421000 |
| Sunday, January 1, 2017 | 2365436000 | 154584000 |
| Monday, January 1, 2018 | 3025137000 | 301034000 |
| Tuesday, January 1, 2019 | 5366000000 | 380833000 |
| Wednesday, January 1, 2020 | 10111000000 | 540099000 |
| Friday, January 1, 2021 | 8482000000 | 701887000 |
| Saturday, January 1, 2022 | 14595000000 | 933013000 |
| Sunday, January 1, 2023 | 16474000000 | 1243336000 |
Data in motion
In the dynamic world of biotechnology, revenue growth is a key indicator of success. Over the past decade, Genmab A/S and Sarepta Therapeutics, Inc. have showcased contrasting trajectories. Genmab A/S, a leader in antibody therapeutics, has seen its revenue skyrocket by nearly 1,800% from 2014 to 2023. This impressive growth reflects its strategic advancements and market penetration. In contrast, Sarepta Therapeutics, Inc., known for its pioneering work in genetic medicine, has experienced a more modest yet significant revenue increase of approximately 12,600% over the same period. While Genmab's revenue reached its peak in 2023, Sarepta's steady climb highlights its resilience and potential in the competitive biotech landscape. These trends underscore the diverse strategies and market dynamics shaping the future of biotechnology.
Revenue Insights: Pfizer Inc. and Sarepta Therapeutics, Inc. Performance Compared
Gilead Sciences, Inc. vs Genmab A/S: Examining Key Revenue Metrics
Vertex Pharmaceuticals Incorporated vs Genmab A/S: Examining Key Revenue Metrics
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Sarepta Therapeutics, Inc.?
Revenue Showdown: United Therapeutics Corporation vs Genmab A/S
Revenue Insights: Genmab A/S and Exelixis, Inc. Performance Compared
Genmab A/S and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Genmab A/S vs Celldex Therapeutics, Inc.
Comparing Revenue Performance: Genmab A/S or Novavax, Inc.?
Revenue Showdown: Sarepta Therapeutics, Inc. vs Perrigo Company plc
Annual Revenue Comparison: Sarepta Therapeutics, Inc. vs Vericel Corporation
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.